Emigre Soviet Scientists Remain Jobless In U.S., Despite Experience

New York alliance offers guidance and support to Russian researchers who are seeking employment in their adopted country Alexander Bolonkin, a mathematician specializing in aerodynamics, has a 10-year gap in his r‚sum‚, from 1972 to 1982, because he was serving time in a Soviet prison camp. Bolonkin is now studying English, but he still has quite a bit to learn; he says he came to the United States "1« hours ago" when he means "1« years ago." Since arriving in the U.S.,

Written byBarbara Spector
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share


New York alliance offers guidance and support to Russian researchers who are seeking employment in their adopted country

And there are many, many more stories of unemployment and underemployment among ‚migr‚ scientists from the Soviet Union, despite a widely predicted shortage of scientists in the U.S. in the coming decades. U.S. refugee-aid groups estimate that approximately 40,000 Soviet ‚migr‚s will arrive in the U.S. this year, 30 percent of whom are scientists or engineers with some R&D experience. Because Jews are one of the few ethnic groups permitted to emigrate from the Soviet Union, most of these scientists are Jewish. Before leaving the U.S.S.R., some of them--known as "re-fuseniks"--spent years awaiting permission from the Soviet authorities to emigrate (The Scientist, Feb. 19, 1990, page 5).

Like Bolonkin and Karabach, many of the ‚migr‚s are finding that education and experience alone are not enough to land jobs. Insufficient knowledge of English ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies